OTC Markets OTCPK - Delayed Quote USD

Nippon Shinyaku Co., Ltd. (NPPNY)

Compare
6.07
0.00
(0.00%)
At close: January 29 at 3:00:00 PM EST
Currency in JPY All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
154,273,000.00
148,255,000.00
144,175,000.00
137,484,000.00
121,859,000.00
Cost of Revenue
49,849,000.00
50,234,000.00
55,980,000.00
50,191,000.00
49,306,000.00
Gross Profit
104,423,000.00
98,021,000.00
88,195,000.00
87,293,000.00
72,553,000.00
Operating Expense
74,136,000.00
64,724,000.00
58,145,000.00
54,345,000.00
45,349,000.00
Operating Income
30,287,000.00
33,297,000.00
30,050,000.00
32,948,000.00
27,204,000.00
Net Non Operating Interest Income Expense
383,000.00
321,000.00
439,000.00
353,000.00
405,000.00
Pretax Income
30,668,000.00
33,616,000.00
30,489,000.00
33,301,000.00
27,608,000.00
Tax Provision
4,612,000.00
7,762,000.00
7,669,000.00
8,303,000.00
8,049,000.00
Net Income Common Stockholders
26,048,000.00
25,851,000.00
22,812,000.00
24,986,000.00
19,540,000.00
Diluted NI Available to Com Stockholders
26,048,000.00
25,851,000.00
22,812,000.00
24,986,000.00
19,540,000.00
Basic EPS
96.69
95.95
84.67
92.74
72.53
Diluted EPS
96.68
95.95
84.67
92.74
72.53
Basic Average Shares
269,408.00
269,407.54
269,408.00
269,412.00
269,412.00
Diluted Average Shares
269,515.23
269,407.54
269,408.00
269,412.00
269,412.00
Total Operating Income as Reported
30,284,000.00
33,295,000.00
30,049,000.00
32,948,000.00
27,202,000.00
Total Expenses
123,985,000.00
114,958,000.00
114,125,000.00
104,536,000.00
94,655,000.00
Net Income from Continuing & Discontinued Operation
26,048,000.00
25,851,000.00
22,812,000.00
24,986,000.00
19,540,000.00
Normalized Income
26,048,000.00
25,851,000.00
22,812,000.00
24,986,000.00
19,540,000.00
Interest Income
720,000.00
650,000.00
575,000.00
472,000.00
531,000.00
Interest Expense
337,000.00
329,000.00
136,000.00
119,000.00
126,000.00
Net Interest Income
383,000.00
321,000.00
439,000.00
353,000.00
405,000.00
EBIT
31,005,000.00
33,945,000.00
30,625,000.00
33,420,000.00
27,734,000.00
EBITDA
36,546,000.00
38,968,000.00
35,666,000.00
38,008,000.00
32,134,000.00
Reconciled Cost of Revenue
49,849,000.00
50,234,000.00
55,980,000.00
50,191,000.00
49,306,000.00
Reconciled Depreciation
5,541,000.00
5,023,000.00
5,041,000.00
4,588,000.00
4,400,000.00
Net Income from Continuing Operation Net Minority Interest
26,048,000.00
25,851,000.00
22,812,000.00
24,986,000.00
19,540,000.00
Total Unusual Items Excluding Goodwill
--
--
--
--
1,998,000.00
Total Unusual Items
--
--
--
--
1,998,000.00
Normalized EBITDA
36,546,000.00
38,968,000.00
35,666,000.00
38,008,000.00
32,134,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
3/31/2021 - 11/16/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CASBF CanSino Biologics Inc.
3.3740
0.00%
 
HLBBF H. Lundbeck A/S
5.60
0.00%
 
HMDCF HUTCHMED (China) Limited
2.9000
-9.52%
 
HLNCF Haleon plc
4.7700
+0.21%
 
IGPK Integrated Cannabis Solutions, Inc.
0.0042
-4.26%
 
ALVO Alvotech
12.41
-1.27%
 
SNOA Sonoma Pharmaceuticals, Inc.
2.6600
-2.92%
 
ALKS Alkermes plc
31.91
+1.11%
 
CPH.TO Cipher Pharmaceuticals Inc.
14.12
+0.50%
 
ELAN Elanco Animal Health Incorporated
12.47
+1.46%